Financials data is unavailable for this security.
View more
Year on year Aroa Biosurgery Ltd had net income fall 2,583.84% from a loss of 396.00k to a larger loss of 10.63m despite a 9.01% increase in revenues from 63.36m to 69.07m. An increase in the selling, general and administrative costs as a percentage of sales from 75.30% to 89.85% was a component in the falling net income despite rising revenues.
| Gross margin | 85.39% |
|---|---|
| Net profit margin | -15.39% |
| Operating margin | -15.45% |
| Return on assets | -9.34% |
|---|---|
| Return on equity | -10.80% |
| Return on investment | -10.11% |
More ▼
Cash flow in NZDView more
In 2024, Aroa Biosurgery Ltd increased its cash reserves by 20.78%, or 1.98m. Cash Flow from Investing totalled 10.15m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 7.38m for operations while cash used for financing totalled 1.03m.
| Cash flow per share | -0.0207 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.25 |
|---|---|
| Tangible book value per share | 0.1982 |
More ▼
Balance sheet in NZDView more
| Current ratio | 7.26 |
|---|---|
| Quick ratio | 6.40 |
| Total debt/total equity | 0.0783 |
|---|---|
| Total debt/total capital | 0.0726 |
More ▼
